Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML

H. Wu, C. Hu, A. Wang, E. L. Weisberg, W. Wang, C. Chen, Z. Zhao, K. Yu, J. Liu, J. Wu, Atsushi Nonami, L. Wang, B. Wang, R. M. Stone, S. Liu, J. D. Griffin, J. Liu, Q. Liu

Research output: Contribution to journalLetter

13 Citations (Scopus)
Original languageEnglish
Pages (from-to)754-757
Number of pages4
JournalLeukemia
Volume30
Issue number3
DOIs
Publication statusPublished - Mar 1 2016
Externally publishedYes

Fingerprint

Leukemic Gene Expression Regulation
Heterocyclic Bridged Bicyclo Compounds
fms-Like Tyrosine Kinase 3
Benzamides
Pyrazoles
STAT5 Transcription Factor
Molecular Targeted Therapy
G1 Phase Cell Cycle Checkpoints
Pyrimidines
Proto-Oncogene Proteins c-akt
Organ Specificity
Protein Kinase Inhibitors
Tumor Cell Line
Acute Myeloid Leukemia
Antineoplastic Agents
Protein-Tyrosine Kinases
Signal Transduction
Phosphorylation
Apoptosis
PCI 32765

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Wu, H., Hu, C., Wang, A., Weisberg, E. L., Wang, W., Chen, C., ... Liu, Q. (2016). Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML. Leukemia, 30(3), 754-757. https://doi.org/10.1038/leu.2015.175

Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML. / Wu, H.; Hu, C.; Wang, A.; Weisberg, E. L.; Wang, W.; Chen, C.; Zhao, Z.; Yu, K.; Liu, J.; Wu, J.; Nonami, Atsushi; Wang, L.; Wang, B.; Stone, R. M.; Liu, S.; Griffin, J. D.; Liu, J.; Liu, Q.

In: Leukemia, Vol. 30, No. 3, 01.03.2016, p. 754-757.

Research output: Contribution to journalLetter

Wu, H, Hu, C, Wang, A, Weisberg, EL, Wang, W, Chen, C, Zhao, Z, Yu, K, Liu, J, Wu, J, Nonami, A, Wang, L, Wang, B, Stone, RM, Liu, S, Griffin, JD, Liu, J & Liu, Q 2016, 'Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML', Leukemia, vol. 30, no. 3, pp. 754-757. https://doi.org/10.1038/leu.2015.175
Wu H, Hu C, Wang A, Weisberg EL, Wang W, Chen C et al. Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML. Leukemia. 2016 Mar 1;30(3):754-757. https://doi.org/10.1038/leu.2015.175
Wu, H. ; Hu, C. ; Wang, A. ; Weisberg, E. L. ; Wang, W. ; Chen, C. ; Zhao, Z. ; Yu, K. ; Liu, J. ; Wu, J. ; Nonami, Atsushi ; Wang, L. ; Wang, B. ; Stone, R. M. ; Liu, S. ; Griffin, J. D. ; Liu, J. ; Liu, Q. / Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML. In: Leukemia. 2016 ; Vol. 30, No. 3. pp. 754-757.
@article{a20acb3d6f4446d5bb25036856fd952b,
title = "Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML",
author = "H. Wu and C. Hu and A. Wang and Weisberg, {E. L.} and W. Wang and C. Chen and Z. Zhao and K. Yu and J. Liu and J. Wu and Atsushi Nonami and L. Wang and B. Wang and Stone, {R. M.} and S. Liu and Griffin, {J. D.} and J. Liu and Q. Liu",
year = "2016",
month = "3",
day = "1",
doi = "10.1038/leu.2015.175",
language = "English",
volume = "30",
pages = "754--757",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML

AU - Wu, H.

AU - Hu, C.

AU - Wang, A.

AU - Weisberg, E. L.

AU - Wang, W.

AU - Chen, C.

AU - Zhao, Z.

AU - Yu, K.

AU - Liu, J.

AU - Wu, J.

AU - Nonami, Atsushi

AU - Wang, L.

AU - Wang, B.

AU - Stone, R. M.

AU - Liu, S.

AU - Griffin, J. D.

AU - Liu, J.

AU - Liu, Q.

PY - 2016/3/1

Y1 - 2016/3/1

UR - http://www.scopus.com/inward/record.url?scp=84959319167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959319167&partnerID=8YFLogxK

U2 - 10.1038/leu.2015.175

DO - 10.1038/leu.2015.175

M3 - Letter

VL - 30

SP - 754

EP - 757

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 3

ER -